- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05206214
Effect of Manual Glide Path Establishment on Endodontic Postoperative Pain
Effect of Manual Glide Path Versus Mechanical Glide Path Establishment on Endodontic Postoperative Pain. A Randomized Clinical Trial
All patients will be treated in a single session approach regardless of the group. All molars will be anesthetized either through infiltration in case of maxillary molars or inferior alveolar nerve block in case of mandibular molars using Octocaine 2% with epinephrine 1: 100,000 (Lidocaine HCl, Novocol Pharmaceutical, Ontario, Canada.). Rubber dam will be applied; and access will be opened using Endo access bur.
In group A manual glide path will be established using manual thermal treated stainless-steel files in a watch winding maneuver. In group B glide path will be established using rotary Ni-Ti files in a reciprocating maneuver. Coronal flaring will be performed using Gates Glidden drill #3 in a brushing motion away from dangerous zone. Root canals will be copiously irrigated using 10 ml 2.5% sodium hypochlorite NaOCl (Clorox; Egyptian Company for household bleach, Egypt) delivered using 28 Gauge safety Steri Irrigation Tip (DiaDent Group International, Burnaby, BC, Canada) inserted 3 mm below cementoenamel junction. Working length will be determined using electronic apex locator Root ZX II (J. Morita Mfg. Corp, Kyoto, Japan) and confirmed radiographically using parallel technique with receptor holding device. Canals were irrigated again with 10ml 1.5% NaOCl, which was delivered 2mm coronal to apical canal terminus. Irrigation was hydro-dynamically agitated with EndoActivator device (Dentsply Maillefer, Baillagues, Switzerland) using blue tips #30/06 inserted 2mm short of working length for 60 seconds.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
All patients will be treated in a single session approach regardless of the group. All molars will be anesthetized either through infiltration in case of maxillary molars or inferior alveolar nerve block in case of mandibular molars using Octocaine 2% with epinephrine 1: 100,000 (Lidocaine HCl, Novocol Pharmaceutical, Ontario, Canada.). Rubber dam will be applied; and access will be opened using Endo access bur.
In group A manual glide path will be established using manual thermal treated stainless-steel files in a watch winding maneuver. In group B glide path will be established using rotary Ni-Ti files in a reciprocating maneuver. Coronal flaring will be performed using Gates Glidden drill #3 in a brushing motion away from dangerous zone. Root canals will be copiously irrigated using 10 ml 2.5% sodium hypochlorite NaOCl (Clorox; Egyptian Company for household bleach, Egypt) delivered using 28 Gauge safety Steri Irrigation Tip (DiaDent Group International, Burnaby, BC, Canada) inserted 3 mm below cementoenamel junction. Working length will be determined using electronic apex locator Root ZX II (J. Morita Mfg. Corp, Kyoto, Japan) and confirmed radiographically using parallel technique with receptor holding device. Canals were irrigated again with 10ml 1.5% NaOCl, which was delivered 2mm coronal to apical canal terminus. Irrigation was hydro-dynamically agitated with EndoActivator device (Dentsply Maillefer, Baillagues, Switzerland) using blue tips #30/06 inserted 2mm short of working length for 60 seconds. Root canals will be shaped using ProTaper next rotary Ni-Ti files (Dentsply Maillefer, Baillagues, Switzerland). Finally, Root canals will be obturated using cold lateral compaction technique. The molars will be permanently restored using composite resin restoration and will be scheduled for extra coronal restoration.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Heba A ElAsfouri, AssProfessor
- Phone Number: +201005276232
- Email: heba.elasfouri@dentistry.cu.edu.eg
Study Contact Backup
- Name: Mostafa I Negm
- Phone Number: 00201227696110
- Email: mostafaibrahim923@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient age above 18-70 years old.
- Both males and females will be included.
- All patients are in a good health without systemic condition.
- The offending tooth is a molar.
- The offending molar is indicated for root canal treatment.
- One molar for every patient.
- All patients will sign an informed consent.
Exclusion Criteria:
- 1. The offending tooth has previous attempt of pulp therapy or root canal treatment.
- 2. The patient showing any clinical or radiographic evidence of periapical pathosis.
3. Patients received analgesics or systemic antibiotic prior to treatment.
-.4 Immunocompromised patients.
- 5. Any unknown infectious disease (e.g. HBV, HCV, HIV, or T.B.)
- 6. History of cancer with radio or chemotherapy.
- 7. Offending molar with mobility score ≥2.
- 8. Offending molar with pocket depth ≥6mm.
- 9. Immature molars.
- 10. Nonodontogenic pain.
- 11. Patients with more than one tooth requiring endodontic intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Manual glide path
manual glide path will be established using manual thermal treated stainless-steel files in a watch winding maneuver
|
manual glide path will be established using manual thermal treated stainless-steel files in a watch winding maneuver. .
Coronal flaring will be performed using Gates Glidden drill #3 in a brushing motion away from dangerous zone.
|
|
Experimental: mechanical glide path
glide path will be established using rotary Ni-Ti files in a reciprocating maneuver
|
glide path will be established using rotary Ni-Ti files in a reciprocating maneuver.
Coronal flaring will be performed using Gates Glidden drill #3 in a brushing motion away from dangerous zone.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative pain
Time Frame: after 4 hours after root canal treatment
|
postoperative pain after root canal treatment using VAS
|
after 4 hours after root canal treatment
|
|
postoperative pain
Time Frame: after 6hours after root canal treatment
|
postoperative pain after root canal treatment using VAS
|
after 6hours after root canal treatment
|
|
postoperative pain
Time Frame: after 12hours after root canal treatment
|
postoperative pain after root canal treatment using VAS
|
after 12hours after root canal treatment
|
|
postoperative pain
Time Frame: after 24hours after root canal treatment
|
postoperative pain after root canal treatment using VAS
|
after 24hours after root canal treatment
|
|
postoperative pain
Time Frame: after 48 hours after root canal treatment
|
postoperative pain after root canal treatment using VAS
|
after 48 hours after root canal treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Heba A ElAsfouri, Cairo university
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 26-12-2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.